Vizz Solution/ Drops
NDC Package 84226-100-11
Package Information
Vizz (aceclidine) solution/ dropses is vIZZ is indicated for the treatment of presbyopia in adults. This formulation utilizes a solution/ drops delivery system. Marketed by Lenz Therapeutics, Inc., this product is identified by NDC 84226-100 and is authorized under FDA application NDA218585.
Identification & Billing
- RxCUI: 2721771 - aceclidine 1.44 % Ophthalmic Solution
- RxCUI: 2721771 - aceclidine 14.4 MG/ML Ophthalmic Solution
- RxCUI: 2721771 - aceclidine 1.44 % (as aceclidine hydrochloride 1.75 % ) Ophthalmic Solution
- RxCUI: 2721776 - VIZZ 1.44 % Ophthalmic Solution
- RxCUI: 2721776 - aceclidine 14.4 MG/ML Ophthalmic Solution [Vizz]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84226 - Lenz Therapeutics, Inc.
- 84226-100 - Vizz
- 84226-100-11 - 5 POUCH in 1 CARTON / 5 AMPULE in 1 POUCH (84226-100-01) / .4 mL in 1 AMPULE
- 84226-100 - Vizz
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (84226-100). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84226-100-11 identifies a specific commercial package of 5 pouch in 1 carton / 5 ampule in 1 pouch (84226-100-01) / .4 ml in 1 ampule of Vizz, a human prescription drug labeled by Lenz Therapeutics, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This solution/ drops is formulated for ophthalmic use and contains aceclidine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lenz Therapeutics, Inc. on July 31, 2025. The current certification is valid through December 31, 2027.
How is this Lenz Therapeutics, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84226010011. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.